Stifel raised the firm’s price target on Henry Schein to $80 from $75 and keeps a Buy rating on the shares. With the stock’s valuation at multi-year lows, the firm believes multiple expansion is probable if its specialty businesses can accelerate, the analyst tells investors. The firm names Henry Schein as one of its favorite stocks within Dental.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HSIC: